Target ACE2, Spike protein
(Unterschied zwischen Versionen)
K |
K |
||
| Zeile 7: | Zeile 7: | ||
{{tp|p=32582574|t=2020. ACE2, Much More Than Just a Receptor for SARS-COV-2.|pdf=|usr=011}} | {{tp|p=32582574|t=2020. ACE2, Much More Than Just a Receptor for SARS-COV-2.|pdf=|usr=011}} | ||
{{tp|p=32738617|t=2020. ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic.|pdf=|usr=018}} | {{tp|p=32738617|t=2020. ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic.|pdf=|usr=018}} | ||
| + | {{tp|p=32602627|t=2020. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.|pdf=|usr=011}} | ||
Version vom 27. April 2021, 18:10 Uhr
ACE2; any specific functions of spike protein;
| PHA antivirals by mechanism |
| PHA pharmacophore by screened target |
| 32449939 2020. SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection. |
32582574 2020. ACE2, Much More Than Just a Receptor for SARS-COV-2.
32738617 2020. ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic.
32602627 2020. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.
| PHA ACE2 Structure spike-ace2 |
| PHA ACE2 in target tissues |
| PHA ACE2 regulation of ACE2 |
| PHA ACE2 drug design |
| PHA ACE2 amplification |
| PHA ACE2 soluble ace2 |
| RSP - On RAS drugs |
| MOD ACE2 transgenic mice |
| PHA ACE2 ace2 species specificity clade specificity |
